3 Stocks Driving The Health Services Industry Higher

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 28 points (-0.2%) at 17,094 as of Thursday, Aug. 28, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,204 issues advancing vs. 1,745 declining with 194 unchanged.

The Health Services industry currently sits down 0.3% versus the S&P 500, which is down 0.1%. Top gainers within the industry include Aetna ( AET), up 0.8%, and Humana ( HUM), up 0.5%. On the negative front, top decliners within the industry include Bio-Reference Laboratories ( BRLI), down 9.0%, Mindray Medical International ( MR), down 2.1%, Sirona Dental Systems ( SIRO), down 1.3%, Grifols ( GRFS), down 1.2% and CR Bard ( BCR), down 1.0%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3. Health Net ( HNT) is one of the companies pushing the Health Services industry higher today. As of noon trading, Health Net is up $0.56 (1.2%) to $46.80 on light volume. Thus far, 245,766 shares of Health Net exchanged hands as compared to its average daily volume of 967,900 shares. The stock has ranged in price between $46.19-$46.87 after having opened the day at $46.21 as compared to the previous trading day's close of $46.24.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Health Net, Inc. provides managed health care services through health plans and government-sponsored managed care plans in the United States. It operates through Western Region Operations and Government Contracts segments. Health Net has a market cap of $3.7 billion and is part of the health care sector. Shares are up 55.9% year-to-date as of the close of trading on Wednesday. Currently there are 4 analysts who rate Health Net a buy, 1 analyst rates it a sell, and 7 rate it a hold.

TheStreet Ratings rates Health Net as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Health Net Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Centene ( CNC) is up $2.10 (2.8%) to $77.74 on average volume. Thus far, 320,252 shares of Centene exchanged hands as compared to its average daily volume of 831,500 shares. The stock has ranged in price between $76.19-$77.82 after having opened the day at $76.19 as compared to the previous trading day's close of $75.63.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Centene Corporation provides multi-line healthcare programs and services in the United States. It operates in two segments, Managed Care and Specialty Services. Centene has a market cap of $4.4 billion and is part of the health care sector. Shares are up 28.3% year-to-date as of the close of trading on Wednesday. Currently there are 8 analysts who rate Centene a buy, no analysts rate it a sell, and 8 rate it a hold.

TheStreet Ratings rates Centene as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, growth in earnings per share, compelling growth in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Centene Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, Edwards Lifesciences ( EW) is up $0.54 (0.6%) to $98.06 on light volume. Thus far, 284,046 shares of Edwards Lifesciences exchanged hands as compared to its average daily volume of 1.0 million shares. The stock has ranged in price between $96.83-$98.15 after having opened the day at $97.68 as compared to the previous trading day's close of $97.52.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. Edwards Lifesciences has a market cap of $10.5 billion and is part of the health care sector. Shares are up 48.3% year-to-date as of the close of trading on Wednesday. Currently there are 10 analysts who rate Edwards Lifesciences a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Edwards Lifesciences as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, solid stock price performance and compelling growth in net income. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Edwards Lifesciences Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

General Electric Booted From Dow, Replaced by Walgreens

General Electric Booted From Dow, Replaced by Walgreens

Dow Plunges on Trade War Worries but Walmart and Verizon Finish Positively

Dow Plunges on Trade War Worries but Walmart and Verizon Finish Positively

Tuesday Turnaround in Politics: Is a Trade War on the Horizon?

Tuesday Turnaround in Politics: Is a Trade War on the Horizon?

FANG Stocks Get Swept Up in Broader Market Selloff

FANG Stocks Get Swept Up in Broader Market Selloff

Snap Shares Plunge After Cowen Cuts Price Target

Snap Shares Plunge After Cowen Cuts Price Target